Tesofensine
Synthetic peptide studied in animal and cell models for clinically demonstrated weight reduction and appetite regulation through central mechanisms
Last updated: March 1, 2026
- Compound
- Tesofensine
- Class
- Body Composition peptide
- Summary
- Synthetic peptide studied in animal and cell models for clinically demonstrated weight reduction, appetite regulation through central mechanisms, metabolic rate enhancement.
- Mechanism
- Integrated Energy Balance Shift
- Research Status
- Phase II
- Routes Studied
- Oral administration (capsule)
- Evidence Level
- Preclinical-promising · Clinically unproven
What Should You Know About Tesofensine?
- What is Tesofensine?
- Tesofensine is a synthetic peptide studied in animal and cell models for clinically demonstrated weight reduction and appetite regulation through central mechanisms.
- Is Tesofensine clinically proven?
- No. Human evidence remains limited and does not establish Tesofensine as clinically proven.
- What has Tesofensine been studied for?
- Tesofensine has been studied in preclinical models of clinically demonstrated weight reduction, appetite regulation through central mechanisms, metabolic rate enhancement. These findings have not been confirmed in large-scale human trials.
- Is Tesofensine approved?
- No. Tesofensine is not an approved drug and remains a research compound.
What Is Tesofensine?
Tesofensine is a small molecule triple monoamine reuptake inhibitor originally developed by NeuroSearch A/S (Denmark) as an investigational treatment for neurodegenerative conditions including Parkinson's disease and Alzheimer's disease. During Phase II clinical trials for these neurological indications, researchers observed consistent and significant body weight reduction in study participants, redirecting research interest toward its metabolic and appetite-regulatory properties. Tesofensine is not a peptide but a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI), included in...
Evidence Summary
Tesofensine is a research compound with promising biological signals but limited human validation. Most claims exceed current clinical evidence.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Clinically Demonstrated Weight Reduction | Limited |
| Appetite Regulation Through Central Mechanisms | Limited |
| Metabolic Rate Enhancement | Limited |
| Cardiometabolic Risk Factor Improvement | Limited |
| Human clinical evidence | Limited |
| Safety data | Insufficient |
Editorial Position
Tesofensine is best understood as a compound with emerging clinical evidence that has not yet reached definitive conclusions. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.
Regulatory Status Snapshot
- Not approved as a therapeutic drug by major regulators
- Safety profile not established in large human populations
Need help interpreting this evidence for your situation?
Talk to a SpecialistA deep research review for Tesofensine is not yet available. This compound profile is based on published peer-reviewed references listed below.
Browse all research reviewsWhat Has Tesofensine Been Studied For?
Research areas where Tesofensine has been investigated in published studies
-
Clinically Demonstrated Weight Reduction Tesofensine has been studied in animal models of clinically demonstrated weight reduction. These findings have not been confirmed in controlled human trials.
-
Appetite Regulation Through Central Mechanisms Tesofensine has been studied in animal models of appetite regulation through central mechanisms. These findings have not been confirmed in controlled human trials.
-
Metabolic Rate Enhancement Tesofensine has been studied in animal models of metabolic rate enhancement. These findings have not been confirmed in controlled human trials.
-
Cardiometabolic Risk Factor Improvement Tesofensine has been studied in animal models of cardiometabolic risk factor improvement. These findings have not been confirmed in controlled human trials.
How Does Tesofensine Work?
These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.
- 01 Triple Monoamine Transporter Inhibition
- 02 Hypothalamic Satiety Signaling Enhancement
- 03 Noradrenergic Metabolic Activation
- 04 Dopaminergic Reward Modulation
Not sure if Tesofensine is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Tesofensine.
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate Tesofensine
How Is Tesofensine Administered?
Tesofensine is available via Oral administration (capsule). Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of Tesofensine?
What Conditions Has Tesofensine Been Linked To?
Have Questions About Tesofensine?
Tesofensine simultaneously inhibits reuptake of three monoamines (serotonin, norepinephrine, and dopamine), addressing appetite, metabolic rate, and food reward processing through convergent central mechanisms. Most other centrally-acting compounds target only one or two neurotransmitter systems.
Published studies on Tesofensine can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.
Tesofensine is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.
Ready to discuss Tesofensine with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026